Related Experiment Video
Updated: Apr 28, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Antibody Responses After BA.5/BF.7 Breakthrough Infection in People Living with HIV
Ying Liu1, Zhaowei Guo2, Zhuo Yang2
1Clinical Center for HIV/AIDS, Beijing Ditan Hospital, Beijing 100015, China.
People living with HIV (PLWH) on suppressive antiretroviral therapy (ART) can develop robust hybrid immunity after COVID-19 vaccination and breakthrough infection. This immunity, comparable to HIV-negative individuals, highlights vaccination
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- People living with HIV (PLWH) are a vulnerable population during the COVID-19 pandemic.
- The immune competence of PLWH on long-term suppressive antiretroviral therapy (ART) to support hybrid immunity remains unclear.
- Functional antibody responses against evolving Omicron subvariants in PLWH are poorly characterized.
Purpose of the Study:
- To assess functional antibody responses in vaccinated and unvaccinated PLWH with breakthrough Omicron subvariant infection.
- To compare antibody neutralization and Fc effector functions in different cohorts.
- To evaluate the impact of ART on hybrid immunity development in PLWH.
Main Methods:
- Three cohorts were enrolled: HIV-negative individuals with breakthrough infection (BTI-HC), vaccinated PLWH with breakthrough infection (BTI-HIV), and unvaccinated PLWH with primary infection (PI-HIV).
- Participants received suppressive ART based on non-nucleoside reverse transcriptase inhibitors or integrase strand transfer inhibitors.
- Measurements included receptor-binding domain (RBD)-specific IgG, neutralizing antibody titers against multiple SARS-CoV-2 variants, and antibody-dependent cellular cytotoxicity (ADCC) responses.
Main Results:
- BTI-HIV participants demonstrated comparable RBD-binding IgG, neutralizing antibody, and ADCC responses to BTI-HC, significantly exceeding PI-HIV.
- Immunological imprinting was observed in breakthrough infection cohorts, with higher neutralizing titers against ancestral D614G than infecting BA.4/5 or BF.7 variants.
- Emerging variants XDV, KP.2, and KP.3 showed substantial neutralization escape across all groups; PI-HIV exhibited diminished neutralization breadth.
Conclusions:
- Suppressive ART enables PLWH to achieve hybrid immunity with neutralizing and ADCC responses comparable to HIV-negative individuals.
- Vaccination is critical for establishing effective hybrid immunity in PLWH, significantly outperforming primary infection in unvaccinated individuals.
- Immunological imprinting and neutralization escape by emerging variants necessitate updated vaccines for HIV-positive populations.
Related Concept Videos
Humoral Immune Responses
Retrovirus Life Cycles
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cross-reactivity
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

